Allarity Therapeutics, Inc. (ALLR)
1.262
+0.01
(+0.96%)
USD |
NASDAQ |
Sep 09, 16:00
1.27
+0.01
(+0.63%)
Pre-Market: 20:00
Allarity Therapeutics Price to Book Value : 5.678 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 5.678 |
| September 08, 2026 | 5.624 |
| September 04, 2026 | 6.390 |
| September 03, 2026 | 6.434 |
| September 02, 2026 | 6.344 |
| September 01, 2026 | 6.390 |
| August 31, 2026 | 6.344 |
| August 28, 2026 | 6.344 |
| August 27, 2026 | 6.210 |
| August 26, 2026 | 6.030 |
| August 25, 2026 | 5.984 |
| August 24, 2026 | 6.254 |
| August 21, 2026 | 6.390 |
| August 20, 2026 | 6.434 |
| August 19, 2026 | 6.434 |
| August 18, 2026 | 6.074 |
| August 17, 2026 | 6.030 |
| August 14, 2026 | 6.164 |
| August 13, 2026 | 6.120 |
| August 12, 2026 | 6.300 |
| August 11, 2026 | 6.434 |
| August 10, 2026 | 6.344 |
| August 07, 2026 | 6.254 |
| August 06, 2026 | 6.300 |
| August 05, 2026 | 5.984 |
| Date | Value |
|---|---|
| August 04, 2026 | 5.894 |
| August 03, 2026 | 5.714 |
| July 31, 2026 | 5.445 |
| July 30, 2026 | 5.534 |
| July 29, 2026 | 5.220 |
| July 28, 2026 | 5.310 |
| July 27, 2026 | 5.534 |
| July 24, 2026 | 5.355 |
| July 23, 2026 | 5.490 |
| July 22, 2026 | 5.760 |
| July 21, 2026 | 5.490 |
| July 20, 2026 | 5.265 |
| July 17, 2026 | 5.355 |
| July 16, 2026 | 5.265 |
| July 15, 2026 | 5.310 |
| July 14, 2026 | 5.220 |
| July 13, 2026 | 5.085 |
| July 10, 2026 | 5.242 |
| July 09, 2026 | 5.400 |
| July 08, 2026 | 5.220 |
| July 07, 2026 | 5.085 |
| July 06, 2026 | 5.400 |
| July 02, 2026 | 5.894 |
| July 01, 2026 | 5.984 |
| June 30, 2026 | 5.804 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.647 |
| Alnylam Pharmaceuticals, Inc. | 25.48 |
| Anika Therapeutics, Inc. | 2.036 |
| Savara, Inc. | 7.742 |
| Vericel Corp. | 5.392 |
Price to Book Value Related Metrics
| PS Ratio | 57.34 |
| Price | 1.262 |
| Earnings Yield | -62.31% |
| Market Cap | 20.08M |